Clinical studies reported to the scientific staff at Biosyntrx have indicated that the antioxidants and phytochemicals in Macula Complete may be effective in slowing down or stopping the progress of early-stage age-related macular degeneration, an eye disorder that gradually destroys central vision. Now it appears that these same formula components may be effective in reducing stroke risk.
A recent study from the University of Melbourne, Australia showed that among 10,405 adults ages 49 to 73, those individuals with early-stage AMD were 87% more likely to suffer a stroke over a ten year period than those without AMD. The likelihood of other risk factors, such as smoking and hypertension increasing stroke risk were also considered. The conclusion: anyone diagnosed with AMD should also be monitored for stroke risk factors, and anything that may reduce AMD risk or progress may also prove to lower the risk of stroke.